Repurposing the yellow fever vaccine for intratumoral immunotherapy. [PDF]
Aznar MA +13 more
europepmc +1 more source
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. [PDF]
Santos-Peral A +19 more
europepmc +1 more source
Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics. [PDF]
Motta E +9 more
europepmc +1 more source
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report. [PDF]
Casey RM +10 more
europepmc +1 more source
Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study. [PDF]
Doshi RH +12 more
europepmc +1 more source
Impact of yellow fever vaccine on patients with psoriasis: preliminary results. [PDF]
de Barros MH, Avelleira JCR, Mendes KAP.
europepmc +1 more source
Related searches:
Origine des vaccins. Developpement du vaccin b17. Preparation des vaccins standards.
openaire +2 more sources

